Neurology News

In patients with acute ischemic stroke with large vessel occlusion who underwent endovascular therapy, tirofiban did not improve outcomes and raised risk for intracerebral hemorrhage, researchers reported.

Cathleen M. McCabe, MD, and Laura B. Enyedi, MD, talk with Jaya B. Kumar, MD, FASRS, and Jullia A. Rosdahl, MD, PhD, about addressing physician suicide and destigmatizing mental health. Plus, they share their favorite resilience hacks.

Endovascular therapy for patients with acute large vessel occlusion with large ischemic core improved their likelihood of achieving a favorable outcome at 90 days by more than twofold vs. medical therapy alone, a speaker reported.

Revisions to diagnostic criteria for sporadic Creutzfeldt-Jakob disease have led to greater accuracy in both clinical care and surveillance, according to a European study published in JAMA Network Open.

Evidence of amyloid abnormality across the Alzheimer’s disease spectrum is more prevalent with cerebrospinal fluid testing, according to a cross-sectional, individual-participant pooled study published in JAMA Neurology.

Continuous professional development for drug prescribing was associated with reduced health care costs for patients, according to findings published in JAMA Network Open.

Burnout, stress and suicide rates have reached “crisis levels” among health care professionals, according to the AMA Alliance.

Riluzole did not improve clinical or radiological outcomes in patients with moderate spinocerebellar ataxia type 2, according to study results published in Lancet Neurology.

A third dose of the COVID-19 vaccine was safe and produced a modest boost in anti-SARS-CoV-2 antibodies in MS patients who experienced a reduced immune response after the first two doses, according to data published in JAMA Neurology.

Anger or emotional upset was associated with all stroke types, according to study findings published in European Heart Journal.